We assume that the observed up-regulation of GLT-1 and EAAT3 glutamate transporters after ischemia represents a self-compensative mechanism in order to modulate extracellular glutamate and attenuate glutamate excitotoxicity. The gene discussed is SLC1A1; the disease is ischemia.